| Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology P Brown, H Inaba, C Annesley, J Beck, S Colace, M Dallas, K DeSantes, ... Journal of the National Comprehensive Cancer Network 18 (1), 81-112, 2020 | 163 | 2020 |
| Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors GW Robinson, AJ Gajjar, KM Gauvain, EM Basu, ME Macy, LD Maese, ... J Clin Oncol 37 (15_suppl), 10009, 2019 | 83 | 2019 |
| Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG) AV Desai, GW Robinson, K Gauvain, EM Basu, ME Macy, L Maese, ... Neuro-oncology 24 (10), 1776-1789, 2022 | 60 | 2022 |
| Donor-derived MDS/AML in families with germline GATA2 mutation P Galera, AP Hsu, W Wang, S Droll, R Chen, JR Schwartz, JM Klco, S Arai, ... Blood, The Journal of the American Society of Hematology 132 (18), 1994-1998, 2018 | 59 | 2018 |
| Inherited TP53 variants and risk of prostate cancer KN Maxwell, HH Cheng, J Powers, R Gulati, EM Ledet, C Morrison, A Le, ... European urology 81 (3), 243-250, 2022 | 57 | 2022 |
| Current use of asparaginase in acute lymphoblastic leukemia/lymphoblastic lymphoma L Maese, RE Rau Frontiers in Pediatrics 10, 902117, 2022 | 39 | 2022 |
| Pathogenic germline variants in cancer susceptibility genes in children and young adults with rhabdomyosarcoma J Kim, N Light, V Subasri, EL Young, T Wegman-Ostrosky, DA Barkauskas, ... JCO Precision Oncology 5, 75-87, 2021 | 37 | 2021 |
| Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study PG Hendrickson, Y Luo, W Kohlmann, J Schiffman, L Maese, AJ Bishop, ... Cancer medicine 9 (21), 7954-7963, 2020 | 36 | 2020 |
| Can recombinant technology address asparaginase Erwinia chrysanthemi shortages? L Maese, C Rizzari, R Coleman, A Power, I van der Sluis, RE Rau Pediatric Blood & Cancer 68 (10), e29169, 2021 | 35 | 2021 |
| Cost‐effectiveness of early cancer surveillance for patients with Li–Fraumeni syndrome CR Tak, E Biltaji, W Kohlmann, L Maese, P Hainaut, A Villani, D Malkin, ... Pediatric blood & cancer 66 (5), e27629, 2019 | 35 | 2019 |
| Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia A Hecht, JA Meyer, A Behnert, E Wong, F Chehab, A Olshen, A Hechmer, ... Haematologica 107 (1), 178, 2022 | 33 | 2022 |
| Clinical utility of pegaspargase in children, adolescents and young adult patients with acute lymphoblastic leukemia: a review C Bender, L Maese, M Carter-Febres, A Verma Blood and Lymphatic Cancer: Targets and Therapy, 25-40, 2021 | 31 | 2021 |
| Stopping leukemia in its tracks: should preemptive hematopoietic stem-cell transplantation be offered to patients at increased genetic risk for acute myeloid leukemia? KV Hamilton, L Maese, JM Marron, MA Pulsipher, CC Porter, KE Nichols Journal of Clinical Oncology 37 (24), 2098-2104, 2019 | 30 | 2019 |
| Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer AJ Church, LB Corson, PC Kao, A Imamovic-Tuco, D Reidy, D Doan, ... Nature medicine 28 (8), 1581-1589, 2022 | 27 | 2022 |
| How is the Ph-like signature being incorporated into ALL therapy? L Maese, SK Tasian, EA Raetz Best Practice & Research Clinical Haematology 30 (3), 222-228, 2017 | 26 | 2017 |
| Germline sequencing improves tumor-only sequencing interpretation in a precision genomic study of patients with pediatric solid tumor J Schienda, AJ Church, LB Corson, B Decker, CM Clinton, DK Manning, ... JCO precision oncology 5, 1840-1852, 2021 | 23 | 2021 |
| Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors. AV Desai, GW Robinson, EM Basu, J Foster, K Gauvain, A Sabnis, ... Journal of Clinical Oncology 38 (15_suppl), 107-107, 2020 | 22 | 2020 |
| Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study L Maese, ML Loh, MR Choi, T Lin, E Aoki, M Zanette, S Agarwal, ... Blood 141 (7), 704-712, 2023 | 20 | 2023 |
| SUMOylation regulates growth factor independence 1 in transcriptional control and hematopoiesis D Andrade, M Velinder, J Singer, L Maese, D Bareyan, H Nguyen, ... Molecular and cellular biology 36 (10), 1438-1450, 2016 | 16 | 2016 |
| Rare FGFR oncogenic alterations in sequenced pediatric solid and brain tumors suggest FGFR is a relevant molecular target in childhood cancer L Lazo De La Vega, H Comeau, S Sallan, A Al-Ibraheemi, H Gupta, YY Li, ... JCO precision oncology 6, e2200390, 2022 | 13 | 2022 |
